Pharmacovigilance

In spite of the current far-reaching tests to which a medicine must be subjected before authorisation, exceptionally risks may only be identified after the market launch when the product is in widespread application and everyday use. The cataloguing of spontaneous reports is still the best way to discover such problems early on.

From 1 January 2021, healthcare professionals should report adverse drug reactions directly to Swissmedic. Further information can be found here.

For the reporting of adverse vaccination reactions connected with the coming COVID vaccines, Swissmedic is currently preparing an adapted report process designed to prioritise the processing and evaluation of these reports.

All the important information about the reporting of adverse drug reactions is provided below: